表紙
市場調査レポート

放射線皮膚炎:世界の治験レビュー

Radiodermatitis Global Clinical Trials Review, H1, 2016

発行 GlobalData 商品コード 296475
出版日 ページ情報 英文 55 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
放射線皮膚炎:世界の治験レビュー Radiodermatitis Global Clinical Trials Review, H1, 2016
出版日: 2016年05月31日 ページ情報: 英文 55 Pages
概要

当レポートでは、世界の放射線皮膚炎治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況およびスポンサー企業タイプ別の臨床試験データを提供しており、概略以下の構成でお届けします。

目次

イントロダクション

  • 放射線皮膚炎
  • レポートガイダンス

臨床試験: 地域別

  • 臨床試験および被験者数: 国別
    • アジア太平洋地域:上位国
    • 欧州:上位5ヶ国
    • 北米:上位国
    • 中東・アフリカ:上位国
    • 中南米:上位国

臨床試験 G7 諸国

臨床試験 G7 諸国: 治験ステータス別

臨床試験 E7 諸国

段階別臨床試験

  • 進行中の治験 :段階別

治験ステータス別臨床試験

一定期間内に募集した被験者

スポンサータイプ別臨床試験

有力なスポンサー

  • 主な治験参加企業

有望な治療薬

臨床試験プロファイル

  • 臨床試験概要: 主要企業
    • ProCertus BioPharm Inc.
    • HealOr Ltd. (Inactive)
    • WATER-JEL Technologies LLC
    • Stemnion, Inc
    • Futurum Group Pty Ltd
    • APEIRON Biologics AG
  • 臨床試験概要: 主要な大学 / 研究機関 / 病院
    • Jewish General Hospital
    • Lancashire Teaching Hospitals NHS Trust
    • Marilia Medical School
    • St Luke's Hospital
    • UMC Utrecht Holding BV
    • Hospital Universitario Virgen del Rocio
    • University of Rochester
    • Rabin Medical Center

5つの主要な臨床試験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3455CTIDB

GlobalData's clinical trial report, "Radiodermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Radiodermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Radiodermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Radiodermatitis to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Radiodermatitis to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Radiodermatitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Radiodermatitis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Radiodermatitis to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Radiodermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Radiodermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Radiodermatitis to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Radiodermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Radiodermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Radiodermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Radiodermatitis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Radiodermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Proportion of Radiodermatitis to Dermatology Clinical Trials, G7 Countries (%), 2016*
  • Radiodermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Radiodermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Radiodermatitis to Dermatology Clinical Trials, E7 Countries (%), 2016*
  • Radiodermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Radiodermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Radiodermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Radiodermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Radiodermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top